Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.
Press releases published on September 19, 2025
2025 Buying Guide - Best Mushroom Supplement Gummies 2025: Why MushCanyon Mushroom Gummies Are the Clear Winner
Washington DC, Sept. 19, 2025 (GLOBE NEWSWIRE) -- MushCanyon proudly launches the 2025 Buyer’s Guide: Best Mushroom Supplement Gummies, a definitive look at the year’s top functional mushroom chewables for focus, immunity, gut health, and daily energy. As …
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million Americans
WARREN, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today expressed its gratitude to the U.S. Department of Health and Human Services (HHS), Secretary Robert F. Kennedy, Jr., and the Trump …
2025 Buying Guide—Best Functional Mushroom Supplement 2025 – Brain, Weight Loss, Gut Health, Energy, -MushCanyon Adaptogens Lineup 2025
washington Dc, Sept. 19, 2025 (GLOBE NEWSWIRE) -- MushCanyon is proud to introduce its 2025 Adaptogens Lineup, a cutting-edge collection of functional mushroom supplements designed to meet the rising demand for natural solutions in brain health, weight …
Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Kensana Health Inc. (“Kensana”) today announced it has entered into a share subscription facility of up to $120 million with GEM Global Yield LLC SCS ("GEM"), a Luxembourg-based alternative investment group. …
Acarpia Farmaceutici und EarlyHealth Group erweitern ihre Partnerschaft, um den Zugang in CARICOM und Mexiko zu verbessern
MAILAND, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., ein italienischer Pharmahersteller, und EarlyHealth Group, ein globaler Pharmadienstleister, haben die Ausweitung ihrer strategischen Partnerschaft bekannt gegeben, um den Zugang zu …
Acarpia Farmaceutici et EarlyHealth Group élargissent leur partenariat afin d’améliorer l’accès à CARICOM et au Mexique
MILAN, 19 sept. 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., un fabricant pharmaceutique italien, et EarlyHealth Group, un prestataire mondial de services pharmaceutiques, ont annoncé l’élargissement de leur partenariat stratégique afin d’ …
Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups
WALTHAM, Mass., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative therapies for age-related degenerative diseases, today announced that Endpoints News has named …
Signature HealthCARE Committed to Proactive Resident Safety with SafeSpace Global Corporation
Knoxville, TN, Sept. 19, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:SSGC), a global leader in multimodal AI technology, is pleased to announce an expanded partnership with Signature HealthCARE. Signature HealthCARE, a family-based …
CrazyBulk 2025 | D-BAL, Testo-max , Trenorol , Ultimate Stack Legal Steroids Alternatives launch BY CrazyBulk In USA.
new york, Sept. 19, 2025 (GLOBE NEWSWIRE) -- NEW YORK, Sep 19, 2025 The Crazy Bulk launch effective Ultimate stack like D-Bal, Testo-Max, Trenorol line of products are designed as a legal and safer alternative to anabolic steroids. Before you read this …
MomentMD Expands Virtual Clinical Education Platform Amid Growing Provider Shortages and Clinical Rotation Crisis
MomentMD Logo FORT LAUDERDALE, Fla., Sept. 19, 2025 (GLOBE NEWSWIRE) -- MomentMD, the first-of-its-kind digital health company providing virtual clinical education, today announced the expansion of its platform to meet surging demand from medical, nursing, …
Sonnet to Present at the MedInvest Biotech & Pharma Conference
PRINCETON, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced …
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 million (USD). The …
NetworkNewsAudio Announces Audio Press Release (APR) on Innovation in Cancer, Rare Disease Treatment Space
AUSTIN, Texas, Sept. 19, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth,” featuring Oncotelic Therapeutics Inc. (OTCQB: OTLC). …
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
[Tainan City], Taiwan, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and …
Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
Vancouver, Canada, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker
Ra’anana, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced the submission of its full pre-submission (Pre- …
NTA Implant: Solidifying Global Leadership with MDR Certification and Launching a New Era in Implantology
EGOLZWIL, Switzerland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- NTA Implant, a leading brand of the Switzerland-based Pilatus Swiss Dental GmbH, has announced a strategic milestone in its global growth journey by successfully completing the rigorous MDR (Medical …
IMUNON to Present New Translational Data of IMNN-001 Supporting Phase 3 Trial of Immunotherapy for Ovarian Cancer at AACR Special Conference in Cancer Research
OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated LAWRENCEVILLE, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated …